Study the Mechanism of Gualou Niubang Decoction in Treating Plasma Cell Mastitis Based on Network Pharmacology and Molecular Docking

Table 2

List of key target proteins.

Target	Degree	Betweenness	Closeness
ALB	44	245.30997	0.8235294
IL6	42	171.66898	0.8
EGFR	42	172.46779	0.8
VEGFA	41	142.68523	0.7887324
CASP3	39	144.2639	0.7671233
MYC	39	169.84193	0.7671233
ESR1	36	108.049736	0.7368421
MMP9	36	67.874886	0.7368421
MMP2	34	42.788708	0.71794873
MAPK1	33	70.23675	0.70886075
FOS	32	92.012405	0.7
ERBB2	32	52.1215	0.7
CXCL8	32	35.600197	0.7
PPARG	31	87.4884	0.69135803
PLG	29	34.790962	0.67469877
ICAM1	28	19.573597	0.6666667
CDKN2A	27	49.359043	0.65882355
TIMP1	27	20.058231	0.65882355
MMP1	27	31.013016	0.65882355
BCL2L1	26	23.144257	0.6511628
HIF1A	25	26.408728	0.6436782
TLR2	25	27.443367	0.6436782
NOS3	23	14.741622	0.6292135
MMP3	23	20.958696	0.6292135
VCAM1	23	15.891444	0.62222224
CRP	23	16.9276	0.61538464
PGR	23	22.414396	0.6292135
CASP9	22	14.892768	0.62222224
IGF2	21	24.814903	0.61538464